StockNews.com Begins Coverage on Athersys (NASDAQ:ATHX)

StockNews.com assumed coverage on shares of Athersys (NASDAQ:ATHX – Free Report) in a research report released on Monday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Athersys Stock Performance Athersys has a 52-week low of $0.01 and a 52-week high of $1.99. The company has a market capitalization of $833,000.00, a […]

Leave a Reply

Your email address will not be published.

Previous post Brooklyn ImmunoTherapeutics (NYSE:BTX) Coverage Initiated at StockNews.com
Next post StockNews.com Initiates Coverage on Culp (NYSE:CULP)